$13.98
0.85% yesterday
Nasdaq, May 20, 10:00 pm CET
ISIN
US52634L1089
Symbol
LNSR

LENSAR Inc Stock price

$13.98
+0.19 1.38% 1M
+6.70 92.03% 6M
+5.04 56.38% YTD
+9.95 246.90% 1Y
+6.75 93.36% 3Y
+4.98 55.33% 5Y
+4.98 55.33% 10Y
Nasdaq, Closing price Tue, May 20 2025
-0.12 0.85%
ISIN
US52634L1089
Symbol
LNSR
Sector

Key metrics

Market capitalization $164.86m
Enterprise Value $155.86m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.73
P/S ratio (TTM) P/S ratio 2.89
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 28.24%
Revenue (TTM) Revenue $57.07m
EBIT (operating result TTM) EBIT $-9.88m
Free Cash Flow (TTM) Free Cash Flow $-4.05m
Cash position $25.25m
EPS (TTM) EPS $-4.85
P/E forward negative
P/S forward 2.42
EV/Sales forward 2.29
Short interest 1.71%
Show more

Is LENSAR Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,789 stocks worldwide.

LENSAR Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

2 Analysts have issued a LENSAR Inc forecast:

2x Hold
100%

Analyst Opinions

2 Analysts have issued a LENSAR Inc forecast:

Hold
100%

Financial data from LENSAR Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
57 57
28% 28%
100%
- Direct Costs 31 31
33% 33%
54%
26 26
24% 24%
46%
- Selling and Administrative Expenses 27 27
19% 19%
47%
- Research and Development Expense 5.42 5.42
9% 9%
9%
-5.79 -5.79
17% 17%
-10%
- Depreciation and Amortization 4.09 4.09
10% 10%
7%
EBIT (Operating Income) EBIT -9.88 -9.88
8% 8%
-17%
Net Profit -57 -57
361% 361%
-99%

In millions USD.

Don't miss a Thing! We will send you all news about LENSAR Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

LENSAR Inc Stock News

Neutral
GlobeNewsWire
13 days ago
14 ALLY Robotic Laser Cataract Systems™ (“ALLY Systems”) placed in 1Q 2025 with an additional backlog of 24 systems pending installation as of March 31, 2025
Neutral
Business Wire
about 2 months ago
NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of LENSAR, Inc. (NasdaqCM: LNSR) to Alcon Inc. (NYSE: ALC). Under the terms of the proposed transaction, shareholders of LENSAR will receive $14.00 in cash, with an additional non-tradeable contingent valu...
Neutral
Business Wire
about 2 months ago
MILWAUKEE--(BUSINESS WIRE)--The Ademi Firm is investigating LENSAR (NASDAQ: LNSR) for possible breaches of fiduciary duty and other violations of law in its transaction with Alcon. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995. There is no cost or obligation to you. In the transaction, LENSAR s...
More LENSAR Inc News

Company Profile

LENSAR, Inc. engages in the development of femtosecond laser technology for refractive cataract surgery. Its product offers automation and customization options for astigmatism treatment planning and other steps of the refractive cataract surgery procedure. The company was founded by Scott Addyman, Randy W. Frey, and Ronald R. Krueger in 2004 and is headquartered in Orlando, FL.

Head office United States
CEO Nicholas Curtis
Employees 140
Founded 2004
Website www.lensar.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today